Key Insights

Highlights

Success Rate

90% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.7%

1 terminated out of 13 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

15%

2 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed with results

Key Signals

3 with results90% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (3)
P 1 (1)
P 4 (2)

Trial Status

Completed9
Terminated1
Recruiting1
Suspended1
Unknown1

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 9 completed trials

Clinical Trials (13)

Showing 13 of 13 trials
Showing all 13 trials

Research Network

Activity Timeline